These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 13374116)

  • 21. Lysergic acid diethylamide: role in conversion of plasma tryptophan to brain serotonin (5-hydroxytryptamine).
    Lin RC; Ngai SH; Costa E
    Science; 1969 Oct; 166(3902):237-9. PubMed ID: 5809595
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A contribution to LSD action on the central cholinergic system.
    Kabes J; Fusek J; Fink Z
    Act Nerv Super (Praha); 1973 May; 15(2):146-7. PubMed ID: 4752663
    [No Abstract]   [Full Text] [Related]  

  • 23. The effects of lysergic acid diethylamide (LSD-25) upon the histochemical reactions for cholinesterase in the central nervous system.
    GOLDBERGER M
    Acta Anat (Basel); 1961; 46():185-91. PubMed ID: 13899716
    [No Abstract]   [Full Text] [Related]  

  • 24. Inhibitory effect of chlorpromazine on alterations in electroencephalograms induced by lysergic acid diethylamide in dogs.
    Djahanguiri B; Guiti N
    Nature; 1966 Oct; 212(5057):87-8. PubMed ID: 5965581
    [No Abstract]   [Full Text] [Related]  

  • 25. LSD and CNS transmission.
    Aghajanian GK
    Annu Rev Pharmacol; 1972; 12():157-68. PubMed ID: 4339014
    [No Abstract]   [Full Text] [Related]  

  • 26. Behavioral evidence for the stimulation of CNS serotonin receptors by high doses of LSD.
    Trulson ME; Ross CA; Jacobs BL
    Psychopharmacol Commun; 1976; 2(2):149-64. PubMed ID: 136010
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The CNS action of d-lysergic acid diethylamide (L.S.D.-25).
    SMITH R
    Mod Hosp; 1953 Jan; 80(1):106-10. PubMed ID: 13025280
    [No Abstract]   [Full Text] [Related]  

  • 28. Effects of psychotomimetic compounds on human pseudocholinesterase.
    FRIED GH; ANTOPOL W
    J Appl Physiol; 1957 Jul; 11(1):25-8. PubMed ID: 13462913
    [No Abstract]   [Full Text] [Related]  

  • 29. A central nervous system effect of a nonhallucinatory lysergic acid derivative.
    SPIRTES MA; GUTH PS; POLLEY EH
    Experientia; 1958 Nov; 14(11):428. PubMed ID: 13609622
    [No Abstract]   [Full Text] [Related]  

  • 30. Experimental data for interaction of morphine and serotoninergic substances and their action upon some CNS-functions.
    Ovtcharov R
    Acta Physiol Pharmacol Bulg; 1982; 8(1-2):64-70. PubMed ID: 6214924
    [No Abstract]   [Full Text] [Related]  

  • 31. [Considerations on the mechanism of action of lysergic acid diethylamine].
    BARBOLINI G; TONINI G
    Boll Soc Ital Biol Sper; 1956; 32(1-2):25-6. PubMed ID: 13374001
    [No Abstract]   [Full Text] [Related]  

  • 32. [Experimental psychosis after administration of benactyzine].
    Vojtĕchovský M; Vítek V; Rysánek K
    Arzneimittelforschung; 1966 Feb; 16(2):240-2. PubMed ID: 4862402
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of reserpine and other drugs on the monoamine metabolism with special reference to the CNS.
    Andén NE
    Ann Med Exp Biol Fenn; 1968; 46(3):361-6. PubMed ID: 4308996
    [No Abstract]   [Full Text] [Related]  

  • 34. [Effects of 5-hydroxy tryptamin (serotonin) and lysergic acid diethylamide (LSD) on the pituitary-adrenal cortex system].
    MILKOVIC S; SUPEK Z
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1956; 228(1-2):146. PubMed ID: 13334585
    [No Abstract]   [Full Text] [Related]  

  • 35. Behavioral evidence for denervation supersensitivity after destruction of central serotonergic nerve terminals.
    Trulson ME; Jacobs BL
    Ann N Y Acad Sci; 1978 Jun; 305():497-509. PubMed ID: 309301
    [No Abstract]   [Full Text] [Related]  

  • 36. Pharmacology of synaptic monoamine transmission.
    Carlsson A
    Prog Brain Res; 1969; 31():53-9. PubMed ID: 4310660
    [No Abstract]   [Full Text] [Related]  

  • 37. [Central effects of lysergic acid diethylamide; studies on the localization of lysergic acid diethylamide effects].
    NEUHOLD K; TAESCHLER M; CERLETTI A
    Helv Physiol Pharmacol Acta; 1957; 15(1):1-7. PubMed ID: 13428196
    [No Abstract]   [Full Text] [Related]  

  • 38. Lysergic acid diethylamide antagonism of certain drugs.
    BROWN BB
    Ann N Y Acad Sci; 1957 Mar; 66(3):677-85. PubMed ID: 13425250
    [No Abstract]   [Full Text] [Related]  

  • 39. Potentiation of bufotenine-like syndrome induced by diethyltryptamine in reserpinized rats.
    Khazan N; Hirsch A; Sulman FG
    Electroencephalogr Clin Neurophysiol; 1967 Jun; 22(6):589. PubMed ID: 4165027
    [No Abstract]   [Full Text] [Related]  

  • 40. The importance of research in biogenic amines for the experimental psychopharmacology.
    Dlabac A
    Act Nerv Super (Praha); 1970; 12(3):215-25. PubMed ID: 4917578
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.